Alternative Investment Instruments
Issue of Convertible Loan Notes & Board Changes | 23-May-2024 | 07:05 | RNS |
Midkine Antibody Licencing Deal | 23-May-2024 | 07:00 | RNS |
Annual Report & Financial Statements - 31 Dec 2023 | 26-Apr-2024 | 07:00 | RNS |
Response to Share Price Movement | 05-Apr-2024 | 07:00 | RNS |
Positive Results: Midkine mRNA and STAT-6 siRNA | 11-Mar-2024 | 07:00 | RNS |
Operations Update | 06-Feb-2024 | 07:00 | RNS |
Change of Auditor | 24-Nov-2023 | 07:00 | RNS |
Significant Mesodermal Killer Cell Milestone | 06-Nov-2023 | 07:00 | RNS |
Interim Results to 30 June 2023 | 27-Sep-2023 | 07:00 | RNS |
Expansion of Patent Portfolio | 14-Aug-2023 | 07:00 | RNS |
Development of New Novel siRNA Therapeutics | 07-Aug-2023 | 07:00 | RNS |
Director/PDMR Shareholding | 02-Aug-2023 | 07:00 | RNS |
Director/PDMR Shareholding | 12-Jul-2023 | 10:27 | RNS |
Results of AGM | 29-Jun-2023 | 10:05 | RNS |
AGM Statement | 29-Jun-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 4.90p |
Change Today | -0.100p |
% Change | -2.00 % |
52 Week High | 9.25 |
52 Week Low | 4.00 |
Volume | 225,000 |
Shares Issued | 129.15m |
Market Cap | £6.33m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
12:52 | 100,000 @ 4.89p |
09:50 | 125,000 @ 4.83p |
You are here: research